Bath & Body Works, Inc. (BBWI)
NYSEConsumer DiscretionarySpecialty RetailSnapshot 2026-10-30
$22.77-0.04%
Close 2026-10-30 · 1-day change
NYSEConsumer DiscretionarySpecialty RetailSnapshot 2026-10-30
Research Workspace
Put BBWI beside peers and holdings, graph the same metric, and keep your notes with the evidence.
Daily closes. Earnings/event dots are placed inline.
Industries move in repeating boom-and-bust cycles. This shows where this stock’s industry sits in that cycle, stage by stage (recovery → expansion → supercycle → steady → deceleration → contraction), from its fundamentals (orders, revenue, capital spending), not the stock’s price.
A booming industry is a tailwind for the names in it; a contracting one is a headwind. Companies in the same industry tend to rise and fall together with the cycle, the way a tide lifts and lowers every boat in the harbor at once, so a large part of a stock’s swing can come from where its industry sits rather than from the company itself. It’s context for reading the company’s results, not a buy/sell call. Full explanation →
Consumer Discretionary is in steady. Describes the industry's cycle state, not a call on this stock.
The stage band shows the industry’s cycle over the chart’s timeline (each color a stage); a ▼ marks a quarter its growth inflected down — amber is an unconfirmed watch, red is confirmed the next quarter. Use “Overlay cycle on chart” to tint the price chart by stage. The industry’s fundamentals, not a signal on this stock.
Primary pillar under pressure — Revenue remains near $7.3 billion in fiscal 2026: Revenue: $1.51B.
View ThesisMiddle-of-the-pack management execution.
View ManagementExpectations look reasonable — what the market is pricing in sits in line with or below what analysts forecast.
View ValuationThis stock is volatile — it swings about 2% on a typical day and fell roughly 39% in its worst 12-month stretch.
View RiskBBWI’s low earnings multiple rests on a cash-backed business, but revenue remains under pressure. Revenue declined year over year in both reported quarters, despite the latest earnings beat. It trades at 7× P/E versus a 15× peer median, with expectations modest versus our view. Our model puts the next-quarter miss probability near 25%. Fiscal 2026 revenue remains near $7.3 billion, leaving the primary pillar under pressure. Peer multiples imply a price about 51% above where it trades; the thesis is on watch. This read is provisional.
Trailing returns as of 2026-10-30. BBWI is total return (includes dividends); the S&P 500 benchmark is price return (the index excludes dividends).
Based on 19 analysts currently covering BBWI (as of Oct 2026).
Based on 9 Wall Street analysts offering 12-month price targets for BBWI in the last 4 months.
Continue this research
Compare BBWI with peers and holdings, graph the same reported metric, keep your questions beside the evidence, and return when the facts change.
Compare now without an account. Saving and monitoring require an account.
| Compare | Company | Living FV | P/E | Revenue % | Quality |
|---|---|---|---|---|---|
| BBWI Selected company | Graph | Compare | Trend | Review | |
| Peer Add a competitor | Graph | Compare | Trend | Review | |
| Holding Compare a holding | Graph | Compare | Trend | Review |
Selected metric trend
Quarterly · checked companies · value or % of revenue
A consensus fair price across 10 valuation methods, at three horizons. As of 2026-10-30. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A price-focused, side-by-side fair-value read versus Other Specialty Retail — fair value, gap to price, and forward P/E.
Compare the value case
Put BBWI next to peers and holdings, compare Living FV and multiples, then graph the driver behind the difference.
Advances: Execute Consumer First Formula transformation
New stores support growth strategy and consumer engagement.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
End-of-day figures as of 2026-10-30. EPS is implied from price ÷ P/E. Not investment advice.
Current $22.77
The last 12 months of price, then the range of analyst 12-month targets from today’s $22.77.
Analyst ratings and price targets are third-party Wall Street estimates, not QuarterlyIQ’s view. Not investment advice.
A long-thesis check that carries the widest uncertainty of the three horizons.
Top 25% on quality vs scored peers
A second lens on the 12-month fair value: for companies that score high on measured quality (profitability, balance-sheet safety, earnings stability), this read trusts more of today's profit margins instead of averaging them toward their multi-year history the way the headline number does. Shown alongside the fair value above, not in place of it. A diagnostic, not a price target or a buy/sell signal.
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
Threatens: Execute Consumer First Formula transformation
E-commerce growth does not offset expected sales decline.
Threatens: Execute Consumer First Formula transformation
Weak demand impacts growth strategy execution.
Advances: Generate $600M free cash flow in 2026
Forecasting EPS supports free cash flow goal.
Threatens: Increase cash from operations
Results beat expectations but lower Q3 earnings forecast.
Advances: Increase cash from operations
Surpassing estimates indicates strong operational performance.
Advances: Increase cash from operations
Increased profit forecast supports cash from operations goal.
Advances: Generate $600M free cash flow in 2026
Exceeding guidance indicates strong progress towards free cash flow target.
